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Purpose: To report genetic and phenotypic discordance across two generations of a family with autosomal recessive
Stargardt disease (STGD1) and to compare pathogenicities of the G1961E and A1038V alleles of the ATP-binding cassette
transporter, subfamily A, member 4 (ABCA4) gene.
Methods: Five members of a family with STGD1 (patients 1–4, affected; patient 5, carrier) were included. Clinical
assessment was performed together with fundus autofluorescence and spectral domain-optical coherence tomography.
Patients were stratified based on the results of electroretinogram testing. Genotyping of the ABCA4 gene was performed
with the ABCR500 microarray.
Results: STGD1 was diagnosed in the male proband and his female sibling (patients 1 and 2, respectively). Two children
of patient 2 (patients 3 and 4) were also affected. Genotyping revealed the W663X stop mutation in all affected patients.
Patients 3 and 4, who were compound heterozygous for the G1961E mutation, had earlier ages of onset than patients 1
and 2, who were compound heterozygous for the A1038V mutation. Patient 1 had an age of onset 28 years younger than
patient 2, whose delayed onset can be explained by relative foveal sparing, while patient 4 had an age of onset 44 years
younger than patient 2.
Conclusions: The G1961E mutation, which has been considered “mild,” yields a more severe phenotype in this family
than the A1038V mutation, which has been considered “severe.” Marked intrasibship discordance in clinical course is
described, suggesting an additional role for modifying factors in ABCA4 pleiotropism.
Autosomal recessive Stargardt disease (STGD1) is the
most  common  cause  of  juvenile  macular  dystrophy.  The
disease prevalence has been estimated between one in 8–
10,000 [1], but it is likely higher since the carrier frequency
of  mutant  ATP-binding  cassette  transporter,  subfamily  A,
member 4 (ABCA4) alleles has been determined to be as high
as 1:20 [2,3]. Since the discovery of the ABCA4 gene as the
molecular cause for STGD1 [4], the phenotypic and genetic
heterogeneity in this disease has been discussed extensively.
While concordance of the disease phenotype within families
is well documented, familial discordance, in the context of
genetic homogeneity, is also a well recognized feature of
ABCA4  disease  [5].  In  this  case  study  we  report  marked
phenotypic discordance in a proband and three affected family
members with STGD1, across two generations.
METHODS
All patients were examined at least once at the Department of
Ophthalmology, Columbia University, by one of the authors
(ST; Figure 1) after informed consent was obtained. None of
the patients had a contributory past medical history. Age of
onset was defined as the age at which visual symptoms were
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first reported. As three of the patients were examined on more
than one occasion, the age at examination and duration of
disease were recalculated for each visit. Visual acuity was
measured using the Early Treatment Diabetic Retinopathy
Study Chart 1. Clinical examination, fundus photography,
fundus autofluorescence (FAF), and spectral domain-optical
coherence  tomography  (SD-OCT;  Heidelberg  Spectralis
HRA+OCT;  Heidelberg  Engineering,  Dossenheim,
Germany)  were  performed  using  standard  acquisition
protocols following pupil dilation with Guttae Tropicamide
Minims 1% (Bausch and Lomb, Surrey, UK). The area of
geographic atrophy (GA) was determined from FAF images
using previously described segmentation software [6]. The
percentage change in GA area from baseline was calculated
for each visit. Ganzfeld full-field electroretinograms (ffERGs;
Diagnosys LLC, Lowell, MA) were recorded from both eyes
in  accordance  with  the  International  Society  for  Clinical
Electrophysiology  of  Vision  standards  [7].  Patients  with
STGD1 were grouped based on the results of their ffERGs
compared with those of age similar controls [8]. The normal
range was defined as the mean±2 standard deviations for age-
similar controls. Those with a normal ffERG had group I
disease.  Genotyping  was  performed  using  the  ABCR500
microarray  and  mutations  were  confirmed  by  direct
sequencing. All research was performed with the approval of
the Institutional Review Board of Columbia University.
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227RESULTS
Demographic, clinical, and genetic information for all patients
is summarized in Table 1. At examination, all five patients
had  normal  anterior  segments  and  intraocular  pressures.
Patient  2  had  the  highest  best  corrected  visual  acuities
(BCVA) of all affected patients in the study, both at baseline
and follow-up. This was explained by relative foveal sparing,
present on both FAF and SD-OCT. Three of the four affected
patients  had  widespread  FAF  abnormalities  (i.e.,  focal
hyperautofluorescent flecks and focal hypoautofluorescence)
throughout  the  posterior  pole,  while  patient  4  had
abnormalities localized to the central macula (Figure 2 and
Figure 3). All affected individuals had evidence of GA, and
all exhibited peripapillary sparing on FAF.
The W663X and A1038V mutations were detected in the
ABCA4 gene in both patients 1 and 2, the latter having an onset
of symptoms at 57 years of age i.e., 28 years later than her
brother. Importantly, this patient had been examined 10 years
beforehand and although “subtle abnormalities in the retina”
were reported, a diagnosis of STGD1 had not been made.
Patients 3 and 4 inherited the W663X mutation maternally and
the G1961E mutation paternally. The maximum discordance
inter-sibship  was  44  years.  Patient  5  was  entirely
asymptomatic  with  bilateral  BCVA  of  20/20.  Sparsely
scattered  hyperautofluorescent  drusen-like  lesions  were
observed throughout the posterior pole in this patient (Figure
2). No corresponding SD-OCT abnormalities were detected.
All affected individuals had normal photopic and scotopic
ERG amplitudes (i.e., group I disease).
DISCUSSION
Both patients 1 and 2 were compound heterozygous for the
W663X and A1038V mutations in the ABCA4 gene. W663X
was previously reported as a disease-causing mutation [9]; it
likely results in a completely dysfunctional protein due to the
stop codon in the first 1/4 of the gene. A1038V, a missense
mutation, is usually reported as a component of the complex
allele L541P/A1038V, one of the most commonly detected
mutations in the ABCA4 gene. A1038V is also known to be
pathogenic without L541P as it has a deleterious effect on
ATPase by ABCA4 in vitro [10,11]. While the complex allele
gives rise to an ABCA4 protein which mislocalizes within the
photoreceptor with a consequent reduction in protein function,
the  protein  associated  with  A1038V  alone  does  not
demonstrate mislocalization [12]. The complex allele gives
rise to a broad spectrum of disease phenotypes [13-15]. The
G1961E missense mutation, which has a deleterious effect on
ABCA4’s ATPase activity, is the most common mutation
detected in the ABCA4 gene and has been reported to confer
a milder phenotype [11,16,17].
All affected patients in this family carried the W663X
mutation,  and  although  G1961E  is  considered  a  “mild”
mutation, both patients with the G1961E mutation had earlier
ages of onset than those with A1038V, which is considered
“severe.”  A  report  by  Cideciyan  et  al.  describing  age  of
disease  onset  in  terms  of  “age  of  retina-wide  disease
initiation” (ADI) suggested that the G1961E mutation results
in a much later ADI than the complex allele L541P/A1038V
[18]. In fact, these mutations were placed on the opposite end
of the ADI spectrum [18]. In this study the retinae of patients
3 and 4 (with the G1961E mutation), at ages of examination
Figure 1. Pedigree of the family. Filled
symbols  indicate  affected  individuals,
the half-filled symbol indicates a carrier
for an ABCA4 mutation. The question
mark in the deceased family member
indicates a possible diagnosis of age-
related macular degeneration.
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229Figure 2. Fundus autofluorescence. Representative images of affected patients 1 (A, B), 3 (C, D), 4 (E, F), and unaffected patient 5 (G, H,
I) are presented. Image I corresponds to the black square region in image H. Geographic atrophy was a prominent feature of Stargardt disease
in the three affected patients, with widespread focal fundus autofluorescence (FAF) abnormalities observed in patients 1 and 3 also.  Images  of 
patient  5  revealed  sparse  discrete  hyperautofluorescent  macular  lesions  bilaterally.  All   subjects  exhibited   peripapillary  sparing   on  FAF
imaging. A corresponding size bar for images A-H is included in A. A size bar for I is included within the image.
Molecular Vision 2012; 18:227-233 <http://www.molvis.org/molvis/v18/a26> © 2012 Molecular Vision
230Figure 3. Images of patient 2. Fundus autofluorescence (FAF) images C and D correspond with the white square regions in images A and
B, respectively. The horizontal white dashed lines represent the position of the spectral domain-optical coherence tomography (SD-OCT)
images E and F on the corresponding en face image. FAF revealed widespread retinal disease. Relative foveal sparing was present bilaterally
as evidenced by a uniform autofluorescence pattern at the foveae (black arrows). The corresponding SD-OCT images revealed relative
preservation of the inner segment–outer segment junctions of the photoreceptors (IS/OS), external limiting membrane (ELM), and outer
nuclear layer (ONL) in this region. The horizontal borders of the regions with preserved IS/OS are indicated by the vertical white dashed lines
on the corresponding FAF and SD-OCT images. Outside these regions, absence of IS/OS was associated with functionally preserved retinal
pigment epithelium (RPE), at least as identified by FAF (C, D). Qualitatively normal thickness RPE was also observed in regions with loss
of IS/OS (F, white arrow).Corresponding size bars for A and B, C and D, and E and F are included in A, C and E, respectively
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Purpose: To report genetic and phenotypic discordance across two generations of a family with autosomal recessive
Stargardt disease (STGD1) and to compare pathogenicities of the G1961E and A1038V alleles of the ATP-binding cassette
transporter, subfamily A, member 4 (ABCA4) gene.
Methods: Five members of a family with STGD1 (patients 1–4, affected; patient 5, carrier) were included. Clinical
assessment was performed together with fundus autofluorescence and spectral domain-optical coherence tomography.
Patients were stratified based on the results of electroretinogram testing. Genotyping of the ABCA4 gene was performed
with the ABCR500 microarray.
Results: STGD1 was diagnosed in the male proband and his female sibling (patients 1 and 2, respectively). Two children
of patient 2 (patients 3 and 4) were also affected. Genotyping revealed the W663X stop mutation in all affected patients.
Patients 3 and 4, who were compound heterozygous for the G1961E mutation, had earlier ages of onset than patients 1
and 2, who were compound heterozygous for the A1038V mutation. Patient 1 had an age of onset 28 years younger than
patient 2, whose delayed onset can be explained by relative foveal sparing, while patient 4 had an age of onset 44 years
younger than patient 2.
Conclusions: The G1961E mutation, which has been considered “mild,” yields a more severe phenotype in this family
than the A1038V mutation, which has been considered “severe.” Marked intrasibship discordance in clinical course is
described, suggesting an additional role for modifying factors in ABCA4 pleiotropism.
Autosomal recessive Stargardt disease (STGD1) is the
most  common  cause  of  juvenile  macular  dystrophy.  The
disease prevalence has been estimated between one in 8–
10,000 [1], but it is likely higher since the carrier frequency
of  mutant  ATP-binding  cassette  transporter,  subfamily  A,
member 4 (ABCA4) alleles has been determined to be as high
as 1:20 [2,3]. Since the discovery of the ABCA4 gene as the
molecular cause for STGD1 [4], the phenotypic and genetic
heterogeneity in this disease has been discussed extensively.
While concordance of the disease phenotype within families
is well documented, familial discordance, in the context of
genetic homogeneity, is also a well recognized feature of
ABCA4  disease  [5].  In  this  case  study  we  report  marked
phenotypic discordance in a proband and three affected family
members with STGD1, across two generations.
METHODS
All patients were examined at least once at the Department of
Ophthalmology, Columbia University, by one of the authors
(ST; Figure 1) after informed consent was obtained. None of
the patients had a contributory past medical history. Age of
onset was defined as the age at which visual symptoms were
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first reported. As three of the patients were examined on more
than one occasion, the age at examination and duration of
disease were recalculated for each visit. Visual acuity was
measured using the Early Treatment Diabetic Retinopathy
Study Chart 1. Clinical examination, fundus photography,
fundus autofluorescence (FAF), and spectral domain-optical
coherence  tomography  (SD-OCT;  Heidelberg  Spectralis
HRA+OCT;  Heidelberg  Engineering,  Dossenheim,
Germany)  were  performed  using  standard  acquisition
protocols following pupil dilation with Guttae Tropicamide
Minims 1% (Bausch and Lomb, Surrey, UK). The area of
geographic atrophy (GA) was determined from FAF images
using previously described segmentation software [6]. The
percentage change in GA area from baseline was calculated
for each visit. Ganzfeld full-field electroretinograms (ffERGs;
Diagnosys LLC, Lowell, MA) were recorded from both eyes
in  accordance  with  the  International  Society  for  Clinical
Electrophysiology  of  Vision  standards  [7].  Patients  with
STGD1 were grouped based on the results of their ffERGs
compared with those of age similar controls [8]. The normal
range was defined as the mean±2 standard deviations for age-
similar controls. Those with a normal ffERG had group I
disease.  Genotyping  was  performed  using  the  ABCR500
microarray  and  mutations  were  confirmed  by  direct
sequencing. All research was performed with the approval of
the Institutional Review Board of Columbia University.
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